N

Novarex Co Ltd
KOSDAQ:194700

Watchlist Manager
Novarex Co Ltd
KOSDAQ:194700
Watchlist
Price: 14 250 KRW -0.21% Market Closed
Market Cap: 267.2B KRW

Novarex Co Ltd
Net Change in Cash

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Novarex Co Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
N
Novarex Co Ltd
KOSDAQ:194700
Net Change in Cash
-â‚©2B
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AmorePacific Corp
KRX:090430
Net Change in Cash
â‚©211.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
8%
Amorepacific Group
KRX:002790
Net Change in Cash
â‚©136B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-2%
Cosmax Inc
KRX:192820
Net Change in Cash
-â‚©91.2B
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
LG H&H Co Ltd
KRX:051900
Net Change in Cash
â‚©639.4B
CAGR 3-Years
117%
CAGR 5-Years
N/A
CAGR 10-Years
19%
Kolmar Korea Co Ltd
KRX:161890
Net Change in Cash
-â‚©55.7B
CAGR 3-Years
N/A
CAGR 5-Years
19%
CAGR 10-Years
-24%
No Stocks Found

Novarex Co Ltd
Glance View

Market Cap
252.3B KRW
Industry
Consumer products

NOVAREX Co., Ltd. engages in the manufacture and sale of dietary supplements. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2018-11-14. is a Korea-based company principally engaged in the manufacturing and distribution of health functional foods. The firm manufactures and sells nutritional supplement products containing vitamins and minerals; individual recognition products which are helpful for body fat reduction, eye health, and joint health; lactic acid bacteria containing products used for skin condition improvement. The firm also produces and sells coenzyme Q10 products, wild mango seed extract products, spirulina products, as well as others. The firm distributes its products within domestic market to overseas markets.

Intrinsic Value
18 501.55 KRW
Undervaluation 23%
Intrinsic Value
Price
N

See Also

What is Novarex Co Ltd's Net Change in Cash?
Net Change in Cash
-2B KRW

Based on the financial report for Jun 30, 2025, Novarex Co Ltd's Net Change in Cash amounts to -2B KRW.

What is Novarex Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
21%

The average annual Net Change in Cash growth rates for Novarex Co Ltd have been 21% over the past three years .

Back to Top